With the aging of our population and sarcopenia becoming of increasing interest, one might speculate that investigative drugs such as the myostatin inhibitors or flavonoids may hold promise for improving muscle strength in postural related progressive kyphosis [22,23]. This evidence concerns the gene MSTN and sarcopenia.